Guidance on Genotoxicity Testing and Data Interpretation for Pharmaceuticals Intended for Human Use

[1]  Louis S. Goodman,et al.  The Pharmacological Basis of Therapeutics. , 1941 .

[2]  J. T. Macgregor,et al.  In vivo rodent erythrocyte micronucleus assay. II. Some aspects of protocol design including repeated treatments, integration with toxicity testing, and automated scoring , 2000, Environmental and molecular mutagenesis.

[3]  Junichiro Saito,et al.  Flow cytometric analysis of micronuclei in peripheral blood reticulocytes: II. An efficient method of monitoring chromosomal damage in the rat. , 2006, Toxicological sciences : an official journal of the Society of Toxicology.

[4]  Takayoshi Suzuki,et al.  In vivo transgenic mutation assays. , 2003, Mutation research.

[5]  D Brusick,et al.  International Commission for Protection Against Environmental Mutagens and Carcinogens. Genotoxicity under extreme culture conditions. A report from ICPEMC Task Group 9. , 1991, Mutation research.

[6]  Makoto Hayashi,et al.  Evaluation of the rat micronucleus test with bone marrow and peripheral blood: Summary of the 9th collaborative study by CSGMT/JEMS·MMS , 1998, Environmental and molecular mutagenesis.

[7]  Sheila M Galloway,et al.  Population doubling: A simple and more accurate estimation of cell growth suppression in the in vitro assay for chromosomal aberrations that reduces irrelevant positive results , 2004, Environmental and molecular mutagenesis.

[8]  Peter Kasper,et al.  Follow-up testing of rodent carcinogens not positive in the standard genotoxicity testing battery: IWGT workgroup report. , 2007, Mutation research.

[9]  Takayoshi Suzuki,et al.  Evaluation of liver and peripheral blood micronucleus assays with 9 chemicals using young rats. A study by the Collaborative Study Group for the Micronucleus Test (CSGMT)/Japanese Environmental Mutagen Society (JEMS)-Mammalian Mutagenicity Study Group (MMS). , 2005, Mutation research.

[10]  T Sofuni,et al.  Report of the IWGT working group on strategies and interpretation of regulatory in vivo tests I. Increases in micronucleated bone marrow cells in rodents that do not indicate genotoxic hazards. , 2007, Mutation research.

[11]  Stephen D Dertinger,et al.  In vivo erythrocyte micronucleus assay III. Validation and regulatory acceptance of automated scoring and the use of rat peripheral blood reticulocytes, with discussion of non-hematopoietic target cells and a single dose-level limit test. , 2007, Mutation research.

[12]  W. Slikker,et al.  Flow cytometric analysis of micronuclei in peripheral blood reticulocytes IV: an index of chromosomal damage in the rhesus monkey (Macaca mulatta). , 2008, Toxicological sciences : an official journal of the Society of Toxicology.

[13]  W. W. Nichols,et al.  Revalidation of the in vitro alkaline elution/rat hepatocyte assay for DNA damage: improved criteria for assessment of cytotoxicity and genotoxicity and results for 81 compounds. , 1996, Mutation research.

[14]  Julie Clements,et al.  Mouse lymphoma thymidine kinase gene mutation assay: Follow‐up International Workshop on Genotoxicity Test Procedures, New Orleans, Louisiana, April 2000 , 2002, Environmental and molecular mutagenesis.

[15]  P. Kasper,et al.  Human biological relevance and the use of threshold-arguments in regulatory genotoxicity assessment: experience with pharmaceuticals. , 2000, Mutation research.

[16]  J. Ashby,et al.  The influence of chemical structure on the extent and sites of carcinogenesis for 522 rodent carcinogens and 55 different human carcinogen exposures. , 1993, Mutation research.

[17]  Isao Yoshimura,et al.  Mouse lymphoma thymidine kinase gene mutation assay: Follow‐up meeting of the international workshop on Genotoxicity testing—Aberdeen, Scotland, 2003—Assay acceptance criteria, positive controls, and data evaluation , 2006, Environmental and molecular mutagenesis.

[18]  A. Wakata,et al.  Evaluation of the rodent micronucleus assay by a 28‐day treatment protocol: Summary of the 13th Collaborative Study by the Collaborative Study Group for the Micronucleus Test (CSGMT)/Environmental Mutagen Society of Japan (JEMS)–Mammalian Mutagenicity Study Group (MMS) , 2001, Environmental and molecular mutagenesis.

[19]  R Scott Obach,et al.  Strategy for genotoxicity testing--metabolic considerations. , 2007, Mutation research.

[20]  The effect of reducing the number of cells scored on the performance of the in vivo rat liver UDS assay. , 1995, Mutation research.

[21]  Trevelyan Square,et al.  Recommendations for conducting the in vivo alkaline Comet assay , 2003 .

[22]  T Sofuni,et al.  Report of the IWGT working group on strategy/interpretation for regulatory in vivo tests II. Identification of in vivo-only positive compounds in the bone marrow micronucleus test. , 2007, Mutation research.

[23]  E Zeiger,et al.  Strategy for genotoxicity testing: hazard identification and risk assessment in relation to in vitro testing. , 2007, Mutation research.

[24]  J. T. Macgregor,et al.  Sensitivity of the erythrocyte micronucleus assay: dependence on number of cells scored and inter-animal variability. , 2007, Mutation research.

[25]  Raffaella Corvi,et al.  How to reduce false positive results when undertaking in vitro genotoxicity testing and thus avoid unnecessary follow-up animal tests: Report of an ECVAM Workshop. , 2007, Mutation research.

[26]  Raffaella Corvi,et al.  ECVAM retrospective validation of in vitro micronucleus test (MNT) , 2008, Mutagenesis.

[27]  M. Fenech,et al.  Report from the In Vitro Micronucleus Assay Working Group , 2003, Mutation research.